In HNSCC, for example, there was moderate increase in H3K27ac at the promoter with decitabine alone and only a slight increase in histone acetylation ahead of the CDKN2A promoter with TSA alone, but a striking increase when TSA and decitabine were used in combination. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.